145 related articles for article (PubMed ID: 37788225)
1. Locally Metastatic Basal Cell Carcinoma.
Porter HJ; Marghoob N; Dinehart M; Goldman G
Dermatol Surg; 2024 Jan; 50(1):101-102. PubMed ID: 37788225
[No Abstract] [Full Text] [Related]
2. Vismodegib: a guide to its use in locally advanced or metastatic basal cell carcinoma.
Lyseng-Williamson KA; Keating GM
Am J Clin Dermatol; 2013 Feb; 14(1):61-4. PubMed ID: 23329081
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of vismodegib in advanced basal-cell carcinoma.
Sekulic A; Migden MR; Oro AE; Dirix L; Lewis KD; Hainsworth JD; Solomon JA; Yoo S; Arron ST; Friedlander PA; Marmur E; Rudin CM; Chang AL; Low JA; Mackey HM; Yauch RL; Graham RA; Reddy JC; Hauschild A
N Engl J Med; 2012 Jun; 366(23):2171-9. PubMed ID: 22670903
[TBL] [Abstract][Full Text] [Related]
4. Vismodegib (Erivedge) for basal cell carcinoma.
Med Lett Drugs Ther; 2012 Jul; 54(1394):53-4. PubMed ID: 22777303
[No Abstract] [Full Text] [Related]
5. Characterization of patients with advanced basal cell carcinoma progressing while receiving Hedgehog pathway inhibitors.
Monnet P; Herms F; Djermane M; Dalac S; Dereure O; Dréno B; Beylot-Barry M; Mortier L; Basset-Seguin N
Br J Dermatol; 2022 Mar; 186(3):579-581. PubMed ID: 34817864
[No Abstract] [Full Text] [Related]
6. Vismodegib, a hedgehog pathway inhibitor for adults with locally advanced or metastatic basal cell carcinoma.
Wilkes GM
Oncology (Williston Park); 2012 Aug; 26(8 Suppl Nurse Ed):31-3. PubMed ID: 25375009
[No Abstract] [Full Text] [Related]
7. Understanding BCC pathogenesis: treatment advancements and challenges.
Goldenberg G; Hamid O
J Drugs Dermatol; 2013 Oct; 12(10):1110-20. PubMed ID: 24085046
[No Abstract] [Full Text] [Related]
8. Defining locally advanced Basal cell carcinoma.
Maly TJ; Sligh JE
J Drugs Dermatol; 2014 May; 13(5):528-9. PubMed ID: 24809873
[No Abstract] [Full Text] [Related]
9. [Vismodegib in metastasized basal cell carcinoma].
Reinders MG; Dirix L; Mosterd K; van Doorn R
Ned Tijdschr Geneeskd; 2013; 157(12):A6011. PubMed ID: 23515044
[TBL] [Abstract][Full Text] [Related]
10. Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma.
Cirrone F; Harris CS
Clin Ther; 2012 Oct; 34(10):2039-50. PubMed ID: 23036338
[TBL] [Abstract][Full Text] [Related]
11. Sonic Hedgehog pathway inhibitors: from clinical trials to clinical practice.
Yan BY; Hibler BP; Menge T; Dunn L; Ho AL; Rossi AM
Br J Dermatol; 2019 May; 180(5):1260-1261. PubMed ID: 30693471
[No Abstract] [Full Text] [Related]
12. Unique Tumor Heterogeneity Within a Single Locally Advanced Basal Cell Carcinoma Resulting in a Partial Response Despite Continuous Vismodegib Treatment.
Nayyar PM; Chang ALS; Sarin K; Ratner D
Dermatol Surg; 2019 Apr; 45(4):608-610. PubMed ID: 30045109
[No Abstract] [Full Text] [Related]
13. A comprehensive review of the role of the hedgehog pathway and vismodegib in the management of basal cell carcinoma.
Erdem GU; Sendur MA; Ozdemir NY; Yazıcı O; Zengin N
Curr Med Res Opin; 2015 Apr; 31(4):743-56. PubMed ID: 25690490
[TBL] [Abstract][Full Text] [Related]
14. Oral hedgehog-pathway inhibitors for basal-cell carcinoma.
Lear JT
N Engl J Med; 2012 Jun; 366(23):2225-6. PubMed ID: 22670909
[No Abstract] [Full Text] [Related]
15. Emergence of a squamous cell carcinoma phenotype following treatment of metastatic basal cell carcinoma with vismodegib.
Iarrobino A; Messina JL; Kudchadkar R; Sondak VK
J Am Acad Dermatol; 2013 Jul; 69(1):e33-4. PubMed ID: 23768306
[No Abstract] [Full Text] [Related]
16. Vismodegib in advanced basal-cell carcinoma.
Babacan T; Sarici F; Altundag K
N Engl J Med; 2012 Sep; 367(10):969-70; author reply 970. PubMed ID: 22931270
[No Abstract] [Full Text] [Related]
17. Vismodegib in advanced basal-cell carcinoma.
Henkin RI
N Engl J Med; 2012 Sep; 367(10):970; author reply 970-1. PubMed ID: 22931271
[No Abstract] [Full Text] [Related]
18. Xanthomatous Dermal Changes in a Patient With Locally Advanced Basal Cell Carcinoma Treated Using Vismodegib.
Smith SDB; Clarke CN; Clark MA; Harker-Murray AK; Sokumbi O
Am J Dermatopathol; 2021 Aug; 43(8):585-587. PubMed ID: 33534208
[TBL] [Abstract][Full Text] [Related]
19. Harnessing hedgehog for the treatment of basal cell carcinoma.
Harms KL; Dlugosz AA
JAMA Dermatol; 2013 May; 149(5):607-8. PubMed ID: 23677088
[No Abstract] [Full Text] [Related]
20. Hedgehog Pathway Inhibition.
Sekulic A; Von Hoff D
Cell; 2016 Feb; 164(5):831. PubMed ID: 26919418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]